1.
Wearable, dropless reduction in intraocular pressure as an emerging therapy for glaucoma.
Waisberg Ethan, Ong Joshua, Masalkhi Mouayad, Lee Andrew G, Berdahl John
Eye (Lond)Mar 20234 citationsReview
Berdahl John
6 articles in GJC
6 articles in GJC
2.
iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes.
Berdahl John, Voskanyan Lilit, Myers Jonathan S, Katz L Jay, Samuelson Thomas W
Clin Exp OphthalmolMay 202020 citationsClinical Trial
iStent inject with prostaglandin significantly and safely reduced intraocular pressure and medication burden for open-angle glaucoma over four years, offering a durable treatment option.
3.
Re: Lindén et al.: Normal-tension glaucoma has normal intracranial pressure: a prospective study of intracranial pressure and intraocular pressure in different body positions (Ophthalmology. 2018;125:361-368).
Baartman Brandon, Sudhagoni Ramu, Swan Russell, Greenwood Michael, Berdahl John
OphthalmologyJun 20181 citationsLetter
4.
Implantation of two second-generation trabecular micro-bypass stents and topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 18-month follow-up.
Berdahl John, Voskanyan Lilit, Myers Jonathan S, Hornbeak Dana M, Giamporcaro Jane Ellen, Katz L Jay et al.
Clin Exp OphthalmolJun 201742 citationsClinical Trial
This study found that two trabecular stents plus one postoperative eye drop significantly lowered intraocular pressure (to ≤13 mmHg) and reduced medication burden safely for 18 months in open-angle glaucoma patients.
5.
Cerebrospinal fluid pressure trends in diseases associated with primary open-angle glaucoma.
Fleischman David, Berdahl John, Stinnett Sandra S, Fautsch Michael P, Allingham R R
Acta OphthalmolSep 201413 citationsRetrospective Studies
6.
Body mass, spinal fluid, and glaucoma.
Fleischman David, Allingham R Rand, Berdahl John, Fautsch Michael
OphthalmologyJun 20117 citationsObservational Study
All 6 articles loaded